Free Trial

National Vision (NASDAQ:EYE) Releases FY24 Earnings Guidance

National Vision logo with Medical background

National Vision (NASDAQ:EYE - Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $0.45-$0.50 for the period, compared to the consensus earnings per share estimate of $0.46. The company issued revenue guidance of $1.82-$1.84 billion, compared to the consensus revenue estimate of $1.83 billion. National Vision also updated its FY 2024 guidance to 0.450-0.500 EPS.

National Vision Trading Down 2.5 %

Shares of NASDAQ:EYE traded down $0.31 during mid-day trading on Wednesday, hitting $11.89. The company had a trading volume of 3,897,130 shares, compared to its average volume of 1,460,263. The company has a market capitalization of $934.98 million, a PE ratio of -11.84, a price-to-earnings-growth ratio of 2.42 and a beta of 1.42. National Vision has a one year low of $9.56 and a one year high of $24.11. The firm has a fifty day moving average price of $10.40 and a 200 day moving average price of $12.66. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.55 and a quick ratio of 0.41.

National Vision (NASDAQ:EYE - Get Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.06 by $0.06. National Vision had a positive return on equity of 3.53% and a negative net margin of 4.00%. The company had revenue of $451.50 million during the quarter, compared to the consensus estimate of $451.13 million. During the same period last year, the business posted $0.09 EPS. The firm's revenue for the quarter was down 15.2% compared to the same quarter last year. As a group, research analysts forecast that National Vision will post 0.23 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on EYE shares. Barclays dropped their price target on shares of National Vision from $16.00 to $11.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 8th. The Goldman Sachs Group lowered their price target on National Vision from $20.00 to $13.00 and set a "neutral" rating for the company in a research report on Friday, August 9th. Finally, UBS Group cut their price objective on shares of National Vision from $20.00 to $18.00 and set a "buy" rating on the stock in a report on Thursday, August 8th. Three equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $15.25.

Read Our Latest Stock Analysis on National Vision

About National Vision

(Get Free Report)

National Vision Holdings, Inc, through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services.

Read More

Earnings History and Estimates for National Vision (NASDAQ:EYE)

→ Financial Prophecy (From Porter & Company) (Ad)

Should you invest $1,000 in National Vision right now?

Before you consider National Vision, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Vision wasn't on the list.

While National Vision currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines